vs
Side-by-side financial comparison of Commercial Vehicle Group, Inc. (CVGI) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
Commercial Vehicle Group, Inc. is the larger business by last-quarter revenue ($154.8M vs $123.8M, roughly 1.3× NATURES SUNSHINE PRODUCTS INC). On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -5.2%). Commercial Vehicle Group, Inc. produced more free cash flow last quarter ($8.7M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -10.8%).
WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
CVGI vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $154.8M | $123.8M |
| Net Profit | — | $4.1M |
| Gross Margin | 9.7% | 72.5% |
| Operating Margin | -1.2% | 4.3% |
| Net Margin | — | 3.3% |
| Revenue YoY | -5.2% | 4.7% |
| Net Profit YoY | — | 1379.4% |
| EPS (diluted) | — | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $154.8M | $123.8M | ||
| Q3 25 | $152.5M | $128.3M | ||
| Q2 25 | $172.0M | $114.8M | ||
| Q1 25 | $169.8M | $113.2M | ||
| Q4 24 | $163.3M | $118.2M | ||
| Q3 24 | $171.8M | $114.6M | ||
| Q2 24 | $193.7M | $110.6M | ||
| Q1 24 | $194.6M | $111.0M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | $-7.1M | $5.3M | ||
| Q2 25 | $-4.8M | $5.3M | ||
| Q1 25 | $-4.3M | $4.7M | ||
| Q4 24 | — | $-321.0K | ||
| Q3 24 | $9.5M | $4.3M | ||
| Q2 24 | $-1.6M | $1.3M | ||
| Q1 24 | $2.9M | $2.3M |
| Q4 25 | 9.7% | 72.5% | ||
| Q3 25 | 10.5% | 73.3% | ||
| Q2 25 | 11.4% | 71.7% | ||
| Q1 25 | 10.5% | 72.1% | ||
| Q4 24 | 8.0% | 72.0% | ||
| Q3 24 | 9.6% | 71.3% | ||
| Q2 24 | 10.6% | 71.4% | ||
| Q1 24 | 11.9% | 71.2% |
| Q4 25 | -1.2% | 4.3% | ||
| Q3 25 | -0.7% | 7.0% | ||
| Q2 25 | 0.5% | 3.7% | ||
| Q1 25 | 0.8% | 5.4% | ||
| Q4 24 | -3.2% | 3.8% | ||
| Q3 24 | -0.6% | 4.6% | ||
| Q2 24 | 0.5% | 5.1% | ||
| Q1 24 | 2.3% | 4.2% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | -4.6% | 4.2% | ||
| Q2 25 | -2.8% | 4.6% | ||
| Q1 25 | -2.5% | 4.2% | ||
| Q4 24 | — | -0.3% | ||
| Q3 24 | 5.5% | 3.8% | ||
| Q2 24 | -0.8% | 1.2% | ||
| Q1 24 | 1.5% | 2.1% |
| Q4 25 | — | $0.23 | ||
| Q3 25 | — | $0.30 | ||
| Q2 25 | — | $0.28 | ||
| Q1 25 | — | $0.25 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $0.23 | ||
| Q2 24 | $-0.05 | $0.07 | ||
| Q1 24 | $0.09 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $93.9M |
| Total DebtLower is stronger | $104.9M | — |
| Stockholders' EquityBook value | $133.4M | $161.6M |
| Total Assets | $391.7M | $261.1M |
| Debt / EquityLower = less leverage | 0.79× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $93.9M | ||
| Q3 25 | — | $95.6M | ||
| Q2 25 | — | $81.3M | ||
| Q1 25 | — | $86.5M | ||
| Q4 24 | — | $84.7M | ||
| Q3 24 | — | $78.7M | ||
| Q2 24 | — | $68.7M | ||
| Q1 24 | — | $77.8M |
| Q4 25 | $104.9M | — | ||
| Q3 25 | $108.2M | — | ||
| Q2 25 | $118.2M | — | ||
| Q1 25 | $117.4M | — | ||
| Q4 24 | $135.5M | — | ||
| Q3 24 | $128.8M | — | ||
| Q2 24 | $142.0M | — | ||
| Q1 24 | $155.7M | $2.1M |
| Q4 25 | $133.4M | $161.6M | ||
| Q3 25 | $136.5M | $166.7M | ||
| Q2 25 | $142.6M | $163.7M | ||
| Q1 25 | $136.7M | $167.1M | ||
| Q4 24 | $135.6M | $161.0M | ||
| Q3 24 | $179.3M | $162.6M | ||
| Q2 24 | $169.6M | $156.4M | ||
| Q1 24 | $175.5M | $159.7M |
| Q4 25 | $391.7M | $261.1M | ||
| Q3 25 | $400.3M | $264.8M | ||
| Q2 25 | $429.8M | $254.9M | ||
| Q1 25 | $419.8M | $252.7M | ||
| Q4 24 | $424.6M | $240.9M | ||
| Q3 24 | $495.3M | $245.3M | ||
| Q2 24 | $503.2M | $235.8M | ||
| Q1 24 | $509.2M | $247.3M |
| Q4 25 | 0.79× | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 1.00× | — | ||
| Q3 24 | 0.72× | — | ||
| Q2 24 | 0.84× | — | ||
| Q1 24 | 0.89× | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $9.9M |
| Free Cash FlowOCF − Capex | $8.7M | $7.6M |
| FCF MarginFCF / Revenue | 5.6% | 6.1% |
| Capex IntensityCapex / Revenue | 2.3% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $34.0M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | $9.9M | ||
| Q3 25 | $-1.7M | $18.5M | ||
| Q2 25 | $18.9M | $4.3M | ||
| Q1 25 | $15.2M | $2.6M | ||
| Q4 24 | $-26.6M | $12.2M | ||
| Q3 24 | $-17.1M | $9.6M | ||
| Q2 24 | $12.6M | $1.3M | ||
| Q1 24 | $-2.4M | $2.2M |
| Q4 25 | $8.7M | $7.6M | ||
| Q3 25 | $-3.5M | $16.8M | ||
| Q2 25 | $17.4M | $3.0M | ||
| Q1 25 | $11.4M | $1.5M | ||
| Q4 24 | $-30.6M | $10.0M | ||
| Q3 24 | $-20.3M | $7.9M | ||
| Q2 24 | $6.4M | $-2.0M | ||
| Q1 24 | $-7.4M | $-1.5M |
| Q4 25 | 5.6% | 6.1% | ||
| Q3 25 | -2.3% | 13.1% | ||
| Q2 25 | 10.1% | 2.6% | ||
| Q1 25 | 6.7% | 1.3% | ||
| Q4 24 | -18.7% | 8.5% | ||
| Q3 24 | -11.8% | 6.9% | ||
| Q2 24 | 3.3% | -1.9% | ||
| Q1 24 | -3.8% | -1.4% |
| Q4 25 | 2.3% | 1.9% | ||
| Q3 25 | 1.2% | 1.3% | ||
| Q2 25 | 0.9% | 1.2% | ||
| Q1 25 | 2.2% | 1.0% | ||
| Q4 24 | 2.4% | 1.9% | ||
| Q3 24 | 1.9% | 1.5% | ||
| Q2 24 | 3.2% | 3.0% | ||
| Q1 24 | 2.6% | 3.3% |
| Q4 25 | — | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.79× | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | -0.80× | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVGI
| Global Seating | $70.7M | 46% |
| Global Electrical Systems | $49.7M | 32% |
| Trim Systems And Components | $34.4M | 22% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
